The EPO published Fenwal's patent application EP3939633A1, a utility patent (Kind A1) for disposable fluid circuits used in extracorporeal photopheresis with an integrated source of photoactive agent. The patent was filed under IPC classifications A61M 1/02 and A61M 1/36 and has been designated across 44 European contracting and extension states including all EU member states, Switzerland, Norway, Turkey, and the United Kingdom.

Healthcare providers and medical device manufacturers should review this patent publication to assess potential impacts on existing or planned photopheresis products and procedures. No immediate compliance action is required as this is an informational patent publication; however, entities developing similar technology should evaluate freedom-to-operate considerations and potential licensing needs.